Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Galectin Therapeutics Inc. - Common Stock (NQ: GALT )

1.040 -0.960 (-48.00%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Other Filings

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Form SC 13D/A
Source: SEC/Edgar
December 13, 2009
Form 8-K
Source: SEC/Edgar
December 09, 2009
Form 424B3
Source: SEC/Edgar
November 23, 2009
Form SC 13D/A
Source: SEC/Edgar
November 22, 2009
Form SC 13D/A
Source: SEC/Edgar
November 22, 2009
Form SC 13D/A
Source: SEC/Edgar
November 22, 2009
Form RW
Source: SEC/Edgar
November 09, 2009
Form 8-K
Source: SEC/Edgar
November 03, 2009
Form SC 13D/A
Source: SEC/Edgar
October 25, 2009
Form SC 13D/A
Source: SEC/Edgar
October 25, 2009
Form SC 13D/A
Source: SEC/Edgar
October 25, 2009
Form 8-K
Source: SEC/Edgar
October 05, 2009
Form 3/A
Source: SEC/Edgar
September 01, 2009
Form SC 13D/A
Source: SEC/Edgar
August 24, 2009
Form SC 13D/A
Source: SEC/Edgar
August 24, 2009
Form SC 13D/A
Source: SEC/Edgar
August 24, 2009
Form 8-K
Source: SEC/Edgar
August 23, 2009
Form 8-K
Source: SEC/Edgar
August 13, 2009
Form 424B3
Source: SEC/Edgar
August 13, 2009
Form SC 13D/A
Source: SEC/Edgar
August 05, 2009
Form SC 13D/A
Source: SEC/Edgar
July 21, 2009
Form SC 13D/A
Source: SEC/Edgar
July 19, 2009
Form 8-K
Source: SEC/Edgar
July 16, 2009
Form 8-K
Source: SEC/Edgar
July 05, 2009
Form SC 13D/A
Source: SEC/Edgar
June 14, 2009
Form EFFECT
Source: SEC/Edgar
June 14, 2009
Form POS AM
Source: SEC/Edgar
June 10, 2009
Form SC 13D/A
Source: SEC/Edgar
June 09, 2009
Form 8-K
Source: SEC/Edgar
May 27, 2009
Form 8-K
Source: SEC/Edgar
May 18, 2009
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.